Elicio Therapeutics Inc (ELTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,240 | -54,573 | -69,463 | -53,759 | -36,687 |
| Depreciation Amortization | 228 | 2,685 | 2,462 | 2,245 | 2,039 |
| Accounts receivable | 806 | -806 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,323 | -866 | 2,072 | 3,736 | 1,112 |
| Other Working Capital | -1,624 | -25,970 | 5,394 | 7,143 | 2,455 |
| Other Operating Activity | 500 | 26,887 | 21,254 | 17,553 | 18,530 |
| Operating Cash Flow | $-15,653 | $-52,643 | $-38,281 | $-23,082 | $-12,551 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -382 | -346 | -285 | -41 |
| Investing Cash Flow | $N/A | $-382 | $-346 | $-285 | $-41 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 302 | N/A | N/A | N/A |
| Debt Repayment | -14 | -9 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 109,346 | 112,308 | 111,515 | 111,254 |
| Common Stock Repurchased | N/A | -10 | -10 | -10 | N/A |
| Other Financing Activity | 0 | -2,458 | -5,531 | -5,437 | -2,810 |
| Financing Cash Flow | $-14 | $107,171 | $106,767 | $106,068 | $108,444 |
| Exchange Rate Effect | -87 | 3 | -11 | 5 | -3 |
| Beginning Cash Position | 88,756 | 34,607 | 34,607 | 34,607 | 34,607 |
| End Cash Position | 73,002 | 88,756 | 102,736 | 117,313 | 130,456 |
| Net Cash Flow | $-15,754 | $54,149 | $68,129 | $82,706 | $95,849 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,653 | -52,643 | -38,281 | -23,082 | -12,551 |
| Capital Expenditure | N/A | -382 | -346 | -285 | -41 |
| Free Cash Flow | -15,653 | -53,025 | -38,627 | -23,367 | -12,592 |